• OFID 2018:5 (Suppl 1) • Poster Abstracts the cephalosporin MIC when combined with clavulanic acid and/or cloxacillin, respectively. A computer-based algorithm was established to interpret the results, which were compared with those of broth microdilution (reference method). Resistance mechanisms of the clinical isolates were assessed by PCR.
Background. Anaplasmosis often presents with fever and headache, and typical laboratory abnormalities include leukopenia and thrombocytopenia. Polymerase chain reaction (PCR) is the preferred diagnostic method. At our institution, Anaplasma PCR is overutilized, with a low positivity rate. To improve utilization, we performed a twopart study. Part 1 determined if complete blood count (CBC) values could exclude Anaplasma infection. A stewardship algorithm was implemented during part 2 of the study via a mock stewardship protocol.
Methods. Part 1: Anaplasma PCR tests were included over a 3-year period. For each PCR result, white blood cell (WBC) and platelet (PLT) results from a sample collected near the time of PCR were evaluated in R Studio and GraphPad Prism. The significance of differences between PCR-positive and -negative cases was determined using the Mann-Whitney test. Cut-off values were chosen to maximize sensitivity of a screening algorithm for the detection of Anaplasma infection. Part 2: Mock stewardship was performed for 6 months. Screening criteria generated in phase 1 were applied to determine whether Anaplasma PCR would have been approved or rejected if stewardship were implemented based on laboratory and clinical parameters.
Results. Part 1: 2166 PCR tests were included. Patients with a positive Anaplasma PCR had lower median WBC and PLT counts than those with a negative result (Figure 1 ). Combining criteria of a WBC ≥11 K/µL and PLT ≥300 K/µL provided rejection criteria with 100% sensitivity and 25% specificity after excluding immunocompromised or unstable patients (Figure 2 ). Part 2: 663 PCR tests were analyzed. Of those, 155 (23%) met CBC rejection criteria and were reviewed by committee. The committee mock refused 110 (71%) tests and mock accepted 49 (29%) based on clinical criteria. Of the patients with positive Anaplasma PCR, 1 met CBC rejection criteria and was mock refused by committee. On review, the patient was completing treatment for Anaplasmosis, indicating limited utility of testing. None of the 45 samples that were mock accepted by clinical criteria was positive by PCR, demonstrating no additional benefit of chart review.
Conclusion. Implementation of a CBC-based stewardship algorithm would reduce unnecessary Anaplasma PCR testing and decrease cost by 23%. Background. Urinalysis (UA) has been routinely used as a screening tool prior to microbial culture set-up in many laboratories. BacterioScan 216Dx instrument utilizes laser light scattering technology to detect bacterial growth in urine and results are available in 3 hours. The aim of this study was to compare the performance of 216 DX and UA against culture as gold standard.
Disclosures
Methods. Clean-catch, unpreserved, either UA positive (leukocyte esterase > trace, or nitrite positive or white blood cells >5/hpf) or UA negative samples from children aged ≤18 years were tested by 216Dx within 24 hours of sample collection. " Likely positive" samples by 216Dx were tested by MALDI-TOF for direct bacterial identification. Sensitivity and specificity of 216Dx and UA was determined against urine culture.
Results. Total of 205 urine samples were included in this study, of which 48.0% (98/205) and 52.0% (107/205) were UA positive and negative, respectively. 77.0% of samples were collected from female and median age was 108 months. Overall sensitivity, specificity, positive, and negative predictive value (PPV and NPV) of 216Dx and UA are shown in table below. Of 27 true positive (TP) samples by 216Dx, 77.0% (21/27) were successfully identified by MALDI-TOF. There were a total of 96 samples identified as contamination/normal flora by culture. Among these, 63 samples (65.0%) were detected as true negative (TN) by 216Dx vs. 50 samples (53.1%) as TN by UA. Two false negative (FN) samples by 216Dx and one FN by UA were K. oxytoca, S. epidermidis (both >100 K cfu/ml) and E. coli (>100 K cfu/mL), respectively.
Conclusion. Although sensitivity of both 216Dx and UA is comparable, specificity of 216Dx was higher than UA. Also, 216Dx showed better performance in detecting urine contamination, thus reducing laboratory reagent and labor cost. Faster turn-around-time of 216Dx coupled with rapid identification of uropathogen by MALDI-TOF has the potential to reduce unnecessary antibiotic use, improve patient management and reduce overall healthcare-related cost.
